Article
Metabolic phenotypes and risk of end-stage kidney disease in patients with type 2 diabetes.
Frontiers in endocrinology - 1 Jan 2023
Zhao Lijun, Zou Yutong, Wu Yucheng, Cai Linli, Zhao Yuancheng, Wang Yiting, Xiao Xiang, Yang Qing, Yang Jia, Ren Honghong, Tong Nanwei, Liu Fang
Abstract excerpt
Background: Obesity often initiates or coexists with metabolic abnormalities. This study aimed to investigate the pathological characteristics and the independent or mutual relations of obesity and metabolic abnormalities with end-stage kidney disease (ESKD) in patients with type 2 diabetes (T2D) and associated diabetic kidney disease (DKD). Methods: A total of 495 Chinese patients with T2D and biopsy-confirmed...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
